Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00183-17
Full Text
Open PDFAbstract
Available in full text
Date
April 3, 2017
Authors
Publisher
American Society for Microbiology